{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:03:41Z","timestamp":1791309821147,"version":"4.3.1"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:label\/>\n                  <jats:p>Cryptococcosis by Cryptococcus gattii is endemic in Colombia, affecting mostly immunocompetent hosts. Since antifungal susceptibility differs between molecular types of cryptococcal isolates, as reported elsewhere, the aim of this study was to determine if 42 Colombian clinical isolates, VGI, VGII and VGIII, differ in the susceptibility to commonly used antifungals, using Sensititre plates. Among the molecular types, six non-wild type isolates to fluconazole, voriconazole, and 5-flucytosine, were identified. Besides, VGI and VGII were less susceptible to 5-flucytosine and azoles, respectively, than other molecular types. These findings support the applicability of practicing susceptibility testing, which could better guide treatment in cryptococcosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Lay Summary<\/jats:title>\n                  <jats:p>Cryptococcosis gattii affects immunocompetent people. For a correct treatment, antifungal susceptibility testing is essential. This study shows differences in the susceptibility to commonly used antimycotics among genotypes of Colombian clinical C. gattii isolates, some of which are non-wild-type.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/mmy\/myab041","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T19:10:20Z","timestamp":1626203420000},"page":"1122-1125","source":"Crossref","is-referenced-by-count":13,"title":["Antifungal susceptibility of clinical <i>Cryptococcus gattii<\/i> isolates from Colombia varies among molecular types"],"prefix":"10.1093","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7547-5172","authenticated-orcid":false,"given":"Carolina","family":"Firacative","sequence":"first","affiliation":[{"name":"Studies in Translational Microbiology and Emerging Diseases (MICROS) Research Group, School of Medicine and Health Sciences, Universidad del Rosario, Bogota, 111221, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Escand\u00f3n","sequence":"additional","affiliation":[{"name":"Group of Microbiology, Instituto Nacional de Salud, Bogota, 111221, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"key":"2021110223541481300_bib1","doi-asserted-by":"crossref","first-page":"a019760","DOI":"10.1101\/cshperspect.a019760","article-title":"Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis","volume":"4","author":"Kwon-Chung","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2021110223541481300_bib2","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1128\/CMR.00126-13","article-title":"Cryptococcus gattii infections","volume":"27","author":"Chen","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"2021110223541481300_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2021110223541481300_bib4","doi-asserted-by":"crossref","first-page":"e3272","DOI":"10.1371\/journal.pntd.0003272","article-title":"Retrospective study of the epidemiology and clinical manifestations of Cryptococcus gattii infections in Colombia from 1997\u20132011","volume":"8","author":"Lizarazo","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2021110223541481300_bib5","first-page":"675213","article-title":"Global molecular epidemiology of Cryptococcus neoformans and Cryptococcus gattii: an atlas of the molecular types","volume":"2013","author":"Cogliati","year":"2013","journal-title":"Scientifica (Cairo)"},{"key":"2021110223541481300_bib6","doi-asserted-by":"crossref","first-page":"e02306","DOI":"10.1128\/mBio.02306-19","article-title":"A new lineage of Cryptococcus gattii (VGV) discovered in the Central Zambezian Miombo woodlands","volume":"10","author":"Farrer","year":"2019","journal-title":"mBio"},{"key":"2021110223541481300_bib7","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/mmi.14565","article-title":"Combatting the evolution of antifungal resistance in Cryptococcus neoformans","volume":"114","author":"Bermas","year":"2020","journal-title":"Mol Microbiol"},{"key":"2021110223541481300_bib8","doi-asserted-by":"crossref","first-page":"e0004861","DOI":"10.1371\/journal.pntd.0004861","article-title":"MLST and whole-genome-based population analysis of Cryptococcus gattii VGIII links clinical, veterinary and environmental strains, and reveals divergent serotype specific sub-populations and distant ancestors","volume":"10","author":"Firacative","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"2021110223541481300_bib9","volume-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008","edition":"3"},{"key":"2021110223541481300_bib10","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1128\/AAC.01115-12","article-title":"Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole","volume":"56","author":"Espinel-Ingroff","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2021110223541481300_bib11","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1128\/AAC.06252-11","article-title":"Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine","volume":"56","author":"Espinel-Ingroff","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2021110223541481300_bib12","doi-asserted-by":"crossref","first-page":"e170391","DOI":"10.1590\/0074-02760170391","article-title":"The war on cryptococcosis: a review of the antifungal arsenal","volume":"113","author":"Mourad","year":"2018","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2021110223541481300_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/jof4010032","article-title":"Cryptococcosis in Colombia: compilation and analysis of data from laboratory-based surveillance","volume":"4","author":"Escandon","year":"2018","journal-title":"J Fungi (Basel)"},{"key":"2021110223541481300_bib14","article-title":"Flucytosine","author":"Padda","year":"2021","journal-title":"StatPearls [Internet]"},{"key":"2021110223541481300_bib15","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","article-title":"Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment","volume":"125","author":"Pfaller","year":"2012","journal-title":"Am J Med"},{"key":"2021110223541481300_bib16","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1128\/JCM.01271-10","article-title":"In vitro susceptibility of the yeast pathogen Cryptococcus to fluconazole and other azoles varies with molecular genotype","volume":"48","author":"Chong","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2021110223541481300_bib17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.diagmicrobio.2012.02.018","article-title":"Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility","volume":"73","author":"Lockhart","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2021110223541481300_bib18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/13693786.2011.602126","article-title":"Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans\/C. gattii species complex","volume":"50","author":"Trilles","year":"2012","journal-title":"Med Mycol"},{"key":"2021110223541481300_bib19","doi-asserted-by":"crossref","first-page":"17258","DOI":"10.1073\/pnas.0402981101","article-title":"A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada)","volume":"101","author":"Kidd","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021110223541481300_bib20","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1086\/597306","article-title":"Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States","volume":"199","author":"Byrnes","year":"2009","journal-title":"J Infect Dis"},{"key":"2021110223541481300_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/jof5020032","article-title":"Clonal dispersal of Cryptococcus gattii VGII in an endemic region of cryptococcosis in Colombia","volume":"5","author":"Firacative","year":"2019","journal-title":"J Fungi (Basel)"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myab041\/39302262\/myab041.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/59\/11\/1122\/40811055\/myab041.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mmy\/article-pdf\/59\/11\/1122\/40811055\/myab041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T23:54:34Z","timestamp":1635897274000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/59\/11\/1122\/6321835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":21,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,7,15]]},"published-print":{"date-parts":[[2021,11,3]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myab041","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11]]},"published":{"date-parts":[[2021,7,15]]}}}